Evidence map›Paper›PMID 40439365›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Recent Advances and Challenges in Cancer Care, with a Focus on Multiple Myeloma, Lymphoma, and Lung Cancer: Key Insights from the Onco Summit 2024-The APAC Chapter.

Ja Min Byun, Won Seog Kim, Myung-Ju Ahn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ja Min ByunDivision of Hematology and Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Won Seog KimCAR-T Cell Therapy Center & Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Myung-Ju AhnDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Onco Summit 2024: The APAC Chapter took place over 2 days, between 16th and 17th February 2024, in South Korea. The event aimed to provide healthcare professionals with the latest updates in different oncology disciplines and share best practices and strategies to ensure optimal patient care. The Summit aimed to foster international and local collaborations to address challenges, understand the future of oncology, and explore opportunities to improve cancer care, especially in the Asia Pacific region. There were 27 scientific presentations and 10 panel discussions with engaging discussions around recent diagnostic and therapeutic advances in cancer care and associated challenges. More than 150 oncology specialists from 11 countries attended the Summit. The Summit highlighted specific challenges in the Asia Pacific region and discussed transferrable strategies to address some of these challenges. This report aims to present a summary of key discussions from the Summit for the global and Asia Pacific oncology community.

Indexed as

Lung NeoplasmsLymphomaMedical OncologyMultiple MyelomaCongresses as TopicHumansCancer care challengeDiagnostic advancesLung cancermultiple myelomaTherapeutic advances

Identifiers

PMID40439365
PMCPMC12290177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.